Klaas Poelstra
Groningen, GR, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Necrotizing enterocolitis: a potential protective role for intestinal alkaline phosphatase as lipopolysaccharide detoxifying enzyme.
Journal: Frontiers in pediatrics
Published: March 14, 2024
Retraction: Interferon gamma peptidomimetic targeted to interstitial myofibroblasts attenuates renal fibrosis after unilateral ureteral obstruction in mice.
Journal: Oncotarget
Published: January 26, 2024
Hepatic Stellate Cell Targeting Using Peptide-Modified Biologicals.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 29, 2023
The role of intestinal alkaline phosphatase in the development of necrotizing enterocolitis.
Journal: Early human development
Published: April 28, 2023
Blood group AB is associated with poor outcomes in infants with necrotizing enterocolitis.
Journal: Journal of pediatric surgery
Published: February 23, 2021
Phosphate Groups in the Lipid A Moiety Determine the Effects of LPS on Hepatic Stellate Cells: A Role for LPS-Dephosphorylating Activity in Liver Fibrosis.
Journal: Cells
Published: September 30, 2020
Rho-kinase inhibitor coupled to peptide-modified albumin carrier reduces portal pressure and increases renal perfusion in cirrhotic rats.
Journal: Scientific reports
Published: September 10, 2018
The antifibrotic potential of a sustained release formulation of a PDGFβ-receptor targeted rho kinase inhibitor.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: June 08, 2018
Pharmacokinetics of a sustained release formulation of PDGFβ-receptor directed carrier proteins to target the fibrotic liver.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: October 09, 2017
Last Updated: 09/26/2026